Pfizer Inc. (PFE)

Price$26.04

Value ScoreB

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-6.76%

Price vs S&P 500 (4W)1.41%

VGM Score55.66

Market Capitalization$148.41B

P/E Ratio (Annual)19.10x

Indicated Dividend Yield (Annual)6.70%

All Metrics

P/CF (Annual)12.68x

Book Value / Share (Quarterly)$15.81

P/TBV (Annual)4.32x

Indicated Dividend (Annual)$1.72

Revenue Growth (3Y)-14.80%

Cash Flow / Share (Quarterly)$1.66

Payout Ratio (TTM)80.25%

Price vs S&P 500 (YTD)-3.58%

Gross Margin (TTM)74.80%

Net Profit Margin (TTM)11.83%

EPS (TTM)$1.31

10-Day Avg Trading Volume32.57M

EPS Excl Extra (TTM)$1.31

Revenue Growth (5Y)8.48%

EPS (Annual)$1.36

Dividend / Share (Annual)$1.72

ROI (Annual)5.14%

Gross Margin (Annual)75.81%

Net Profit Margin (5Y Avg)17.33%

Cash / Share (Quarterly)$2.29

P/E Basic Excl Extra (TTM)19.81x

Revenue Growth QoQ (YoY)5.36%

EPS Growth (5Y)-3.51%

P/E Normalized (Annual)19.10x

ROA (Last FY)3.73%

Revenue Growth TTM (YoY)1.36%

EBITD / Share (TTM)$2.55

ROE (5Y Avg)16.35%

Operating Margin (TTM)15.36%

Cash Flow / Share (Annual)$1.60

P/B Ratio1.65x

P/B Ratio (Quarterly)1.75x

Net Income / Employee (Annual)$103,600

EV / Revenue (TTM)3.34x

Net Interest Coverage (TTM)5.02x

ROA (TTM)3.61%

EPS Growth QoQ (YoY)-9.77%

EV / EBITDA (TTM)14.49x

EPS Incl Extra (Annual)$1.36

Current Ratio (Annual)1.16x

Quick Ratio (Quarterly)0.94x

3-Month Avg Trading Volume39.50M

52-Week Price Return12.63%

EV / Free Cash Flow (Annual)23.27x

P/E Incl Extra (TTM)19.81x

Revenue / Employee (TTM)$844,200

Tangible BV / Share (Quarterly)$6.59

P/S Ratio (Annual)2.37x

Asset Turnover (Annual)0.30x

52-Week High$28.75

Operating Margin (5Y Avg)18.78%

EPS Excl Extra (Annual)$1.36

CapEx CAGR (5Y)-1.19%

Tangible BV CAGR (5Y)-1.19%

26-Week Price Return1.17%

Quick Ratio (Annual)0.87x

13-Week Price Return-2.14%

Total Debt / Equity (Annual)0.75x

Current Ratio (Quarterly)1.25x

Enterprise Value$211.17B

Revenue / Share Growth (5Y)8.17%

Asset Turnover (TTM)0.30x

Book Value / Share Growth (5Y)6.01%

Revenue / Employee (Annual)$834,400

Inventory Turnover (Annual)1.41x

Pretax Margin (Annual)12.02%

Cash / Share (Annual)$2.39

3-Month Return Std Dev19.83%

Gross Margin (5Y Avg)69.76%

Net Income / Employee (TTM)$99,900

EBITDA CAGR (5Y)5.56%

EBITDA Interim CAGR (5Y)-5.09%

ROE (Last FY)8.99%

Net Interest Coverage (Annual)5.35x

EPS Basic Excl Extra (Annual)$1.36

P/FCF (TTM)13.89x

Receivables Turnover (TTM)5.18x

EV / Free Cash Flow (TTM)22.27x

Total Debt / Equity (Quarterly)0.72x

EPS Incl Extra (TTM)$1.31

Receivables Turnover (Annual)5.36x

ROI (TTM)4.91%

Dividend Growth Rate (5Y)2.51%

P/S Ratio (TTM)2.34x

Pretax Margin (5Y Avg)18.13%

Revenue / Share (Annual)$10.95

Tangible BV / Share (Annual)$5.76

Forward P/E9.01x

Free OCF CAGR (5Y)-4.81%

Price vs S&P 500 (52W)-11.74%

P/E Ratio (TTM)19.81x

EPS Growth TTM (YoY)-5.26%

Year-to-Date Return4.58%

5-Day Price Return1.60%

EPS Normalized (Annual)$1.36

ROA (5Y Avg)7.29%

Net Profit Margin (Annual)12.42%

Month-to-Date Return-0.53%

Cash Flow / Share (TTM)$2.92

EBITD / Share (Annual)$2.50

EPS Growth (3Y)-37.13%

Operating Margin (Annual)15.01%

LT Debt / Equity (Annual)0.71x

P/CF (TTM)12.38x

ROI (5Y Avg)10.92%

P/E Excl Extra (TTM)19.81x

LT Debt / Equity (Quarterly)0.67x

EPS Basic Excl Extra (TTM)$1.31

P/TBV (Quarterly)4.21x

Payout Ratio (Annual)125.75%

P/B Ratio (Annual)1.64x

Dividend / Share (TTM)$1.72

Inventory Turnover (TTM)1.48x

Pretax Margin (TTM)12.49%

Book Value / Share (Annual)$15.21

Price vs S&P 500 (13W)-10.40%

Net Margin Growth (5Y)-10.80%

Dividend Yield (TTM)6.59%

Beta0.28x

P/FCF (Annual)16.35x

Revenue / Share (TTM)$11.05

ROE (TTM)8.37%

52-Week Low$23.08

vGradeB

gGradeC

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.75est. 0.72

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

3.43

3.49

3.47

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
PFEPfizer Inc.	B	C	C	$26.04
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
BMYBristol-Myers Squibb Co.	B	C	B	$57.27
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	B	$34.19

About

Pfizer is among the world's largest pharmaceutical companies with approximately $60 billion in annual sales, primarily from prescription drugs and vaccines. Key revenue drivers include blockbuster therapies Prevnar 13, Vyndaqel, and Eliquis, with international markets—particularly emerging economies—accounting for 40% of total sales.